🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats to the influencers of #ACR24 & thanks for all your posts sharing knowledge from the conference!!! 🥳 American College of Rheumatology Rheum Cat Dr. John Cush Mithu Maheswaranathan, MD Mike Putman Theodora Lasso Defying Gravity 🩷🇧🇸 @NamrataRheum Cheryl Crow, Arthritis Life 𝓛𝓲𝓼𝓪 🐳🗺🧭 #Rheumatology

Thanks to everyone who came to my poster on #HealthLiteracy & outcomes in #InflammatoryArthritis at #ACR24 Great to connect with rheumatologists, researchers & patients from around the world working on #SocialDeterminantsOfHealth Full abstract is here: acrabstracts.org/abstract/healt…

🔥 Visual Abstract w/ Healio Rheumatology 🟢 💉 RCT of semaglutide (GLP-1) vs Placebo in OA 🦵 Pts w/ obesity (BMI ≥ 30), knee OA + WOMAC score ≥ 40 ⭐ Results: significantly ⇣ weight and ⇣ pain in semaglutide group (vs PBO) 📝: tinyurl.com/semaglutideOA #Osteoarthritis #RheumX

Excited to have the opportunity to present on Physician #Burnout in Rheumatology at Grand Rounds today. Thankful many on #RheumTwitter have been voices here on this important topic in our current healthcare climate & trend of physicians exiting clinical medicine!

Happy holidays from the Duke Rheum crew ❄️⛄️🎄 Mithu Maheswaranathan, MD @DavidLeverenz Dahima Cintron Phil Chu, MD, RhMSUS

📑 NEJM data shows B-cell depletion with Amgen 🧪🔬🧬’s #inebilizumab is effective for #IgG4RD: ⬇️Reduced disease flare rate by 87% ⬆️ Boosted complete remission without extra steroids 🔗bit.ly/3ZTYW66 😶‍🌫️Foggy on the data? Mithu Maheswaranathan, MD Rheum OnePagers shares 🔑insights

Report in NEJM describing the first critically ill adolescent with #H5N1 D1.1 (aka #BirdFlu) in North America. A 13 yo rapidly progressed from mild symptoms to respiratory & renal failure. She survived thanks to IMV + ECMO + CRRT. Scary stuff. 📄 nejm.org/doi/full/10.10…

🎉 #RheumMadness is Back!!! 🎧

🚨Apparently all NIH Study Sections have been suspended indefinitely. For those who don’t know, this means there won’t be any review of grants submitted to NIH Depending on how long this goes on for, this could lead to an interruption in billions in research funding.

Second edition of Rheumatology Made Ridiculously Simple is out now! This edition we actually have a professional artist and are no longer relying on my own bad drawings! #meded #rheumatology

It was an honor to present alongside these two esteemed physician-scientists who have pushed the frontiers of transplantation and cell therapy for patients with autoimmune disorders. #Tandem25 tandemmeetingsnews.com/experts-trace-…

💫 Check out the new #RheumMadness x @ RheumOnePagers Bracket Infographic 🏀📟 📚 Read the most innovative #rheum articles (last 2 yrs) 🎧 Check out the Rheum Madness Podcasts 🗳️ Submit your Brackets before April 1, 2025 Collaboration with Rheum Madness Team x @DavidLeverenz

🆕 PJP Prophylaxis in #Rheumatology 🫁 Created with / Review by Cassandra Calabrese 🔹Discuss risk factors for PJP infection 🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk 🔹Review Treatment options and when to stop PPx? #RheumX #RheumTwitter #PulmTwitter #PJP

🆕 UPDATE: Inebilizumab is now the first FDA approved therapy for IgG4-RD 🚨